You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. An Innovative Software Tool for Blades Stress Estimation during Multiple Simultaneous Vibratory Mode

    SBC: Advanced Dynamics, Inc.            Topic: AF11BT22

    ABSTRACT: ADI and ASU propose to develop a novel methodology for blade peak stress prediction from limited strain gage/tip-timing measurements when multiple vibratory modes are present. The current protocol assumes that only one mode is present and only provides upper and lower bound estimates of the blade peak stress when multiple modes are important. It is proposed here to construct the blade m ...

    STTR Phase I 2012 Department of DefenseAir Force
  2. Assured Information Sharing in Clouds

    SBC: INFOBEYOND TECHNOLOGY LLC            Topic: AF11BT30

    ABSTRACT: In the future, numerous military database, documentation, and mission-critical information systems will be migrated to the clouds, due to cloud cost-efficiency and accessing flexibility. However, the cloud servers are generally untrusted either for data owners or users. In this proposal, A3IS (Attribute-based Algorithms for Assured Information Sharing) is proposed for dynamically and se ...

    STTR Phase I 2012 Department of DefenseAir Force
  3. Development of a Novel Therapeutic for Alzheimer' Disease

    SBC: CoPlex Therapeutics, LLC            Topic: NIA

    DESCRIPTION (provided by applicant): Traditional approaches to drug development for Alzheimer's disease are becoming increasingly expensive and in many cases disappointingly unsuccessful. Based on preliminary in vitro and in vivo studies we have identifieda novel lactam derivative of the commonly prescribed 1,4 dihydropyridine calcium channel blocker nifedipine (1-acetyl-2,4- dimethylbenzo[c] ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Long-Term Broad-Spectrum Prevention of Implant-Related Infections

    SBC: Biomedical Development Corporation            Topic: NIA

    DESCRIPTION (provided by applicant): Deep wound infection following total joint arthroplasty is a devastating complication for physician and patient, a leading cause of morbidity, and a significant economic burden to the healthcare system. With an aging population and increased life expectancies, the number of arthroplasties is expected to rise dramatically over the next 20 years. The growing numb ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Delayed Tolerance Induction in Living Related Donor Renal Transplant Recipients

    SBC: REGENEREX, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): We have developed a protocol that reproducibly induces transplantation tolerance in individuals undergoing a living related donor kidney transplant. Three subjects have been off all immunosuppression for 10 months, 2 months, and 1 month respectively and have remained chimeric with stable renal function. Two additional chimeric subjects are in various stages of ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Medical Sensor Applications of Tunnel Magnetoresistance (TMR)

    SBC: Koronis Biomedical Technologies Corp.            Topic: NIDCD

    DESCRIPTION (provided by applicant): Koronis Biomedical Technologies (KBT) proposes to develop a novel tunneling magnetoresistance (TMR) sensor for use in medical devices. TMR technology delivers improvements in magnetic sensor size, sensitivity, and noiserejection that represent an opportunity to significantly enhance the performance of a variety of medical devices that currently rely on traditio ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Development of a Plasma Biomarker of Alzheimer's Disease

    SBC: SCOUT DIAGNOSTICS            Topic: NIEHS

    DESCRIPTION (provided by applicant): The major barriers to preventing or treating Alzheimer's disease (AD) are its unknown pathogenesis/etiology and the lack of an objective, sensitive and specific biomarker of the disease, particularly at the early stageswhen therapeutic interventions would likely have the greatest efficacy. The basic hypothesis of this application is that plasma levels of a ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Neurocognitive Training to Improve Executive Function

    SBC: Koronis Biomedical Technologies Corp.            Topic: NCATS

    DESCRIPTION (provided by applicant): In this Phase I STTR project Koronis Biomedical Technologies (KBT) in close collaboration with the Zelazo Lab at the University of Minnesota proposes to develop an electroencephalography (EEG) based neurocognitive training tool to enable individuals to improve neurocognitive processes associated with executive function (EF). Processes involved in self-control a ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. The Bumps, a device for rapid, non invasive quantification of touch sensation

    SBC: Neuro Devices, Inc.            Topic: NCATS

    DESCRIPTION (provided by applicant): This application describes an elegantly simple, pocket size device, called the Bumps that rapidly quantifies the important sensation of touch on the fingers in micrometer ( m) units. This high sensitivity differentiates the small variations f touch sensation that exist between healthy subjects and can detect minor reduction of touch sensation in fingers of ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Transdermal Naltrexone for Opiate Addiction and Alcoholism

    SBC: ALLTRANZ, INC.            Topic: NIDA

    DESCRIPTION (provided by applicant): According to the National Survey of Drug Use and Health (NSDUH) of 2008, 7.2 million Americans are in need of treatment for Substance-Related Disorders (SRDs), and a large proportion of those need treatment for opiate pain reliever, heroin, and alcohol addiction. Naltrexone (NTX), an opioid antagonist, is currently used in oral tablet form to help maintain opio ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government